Comparative review of dopamine receptor agonists in Parkinson's disease

被引:84
作者
Uitti, RJ [1 ]
Ahlskog, JE [1 ]
机构
[1] MAYO CLIN, MAYO CLIN DIV MOVEMENT DISORDERS, ROCHESTER, MN USA
关键词
D O I
10.2165/00023210-199605050-00006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Limitations of long term levodopa therapy for Parkinson's disease represent a major problem in the management of many patients. Dopamine receptor agonists provide antiparkinsonian effects and their use is most clearly defined in the context of complications from levodopa therapy. As such, dopamine receptor agonists are useful adjunctive agents to levodopa. Because typical adverse effects of dopamine receptor agonists may differ from those of levodopa, combination therapy is often effective and well tolerated. A variety of dopamine receptor agonists, both ergot and non-ergot derivatives, are useful in the treatment of Parkinson's disease. Five dopamine receptor agonists are currently available for use throughout much of the world, and many more are in developmental phases. Varying pharmacodynamic and pharmacokinetic profiles allow selection of appropriate dopamine receptor agonists for specific clinical scenarios. Recently reported comparative studies also suggest certain prescribing recommendations.
引用
收藏
页码:369 / 388
页数:20
相关论文
共 123 条
[1]   DOPAMINE AGONIST TREATMENT OF FLUCTUATING PARKINSONISM - D-2 (CONTROLLED-RELEASE MK-458) VS COMBINED D-1 AND D-2 (PERGOLIDE) [J].
AHLSKOG, JE ;
MUENTER, MD ;
BAILEY, PA ;
STEVENS, PM .
ARCHIVES OF NEUROLOGY, 1992, 49 (05) :560-568
[2]   FLUCTUATING PARKINSONS-DISEASE - TREATMENT WITH THE LONG-ACTING DOPAMINE AGONIST CABERGOLINE [J].
AHLSKOG, JE ;
MUENTER, MD ;
MARAGANORE, DM ;
MATSUMOTO, JY ;
LIEBERMAN, A ;
WRIGHT, KF ;
WHEELER, K .
ARCHIVES OF NEUROLOGY, 1994, 51 (12) :1236-1241
[3]   TREATMENT OF PARKINSONS-DISEASE WITH PERGOLIDE - A DOUBLE-BLIND-STUDY [J].
AHLSKOG, JE ;
MUENTER, MD .
MAYO CLINIC PROCEEDINGS, 1988, 63 (10) :969-978
[4]  
AHLSKOG JE, IN PRESS CLIN NEUROP
[5]  
Albani C, 1992, MOV DISORD S1, V7, P98
[6]   PARALLEL ORGANIZATION OF FUNCTIONALLY SEGREGATED CIRCUITS LINKING BASAL GANGLIA AND CORTEX [J].
ALEXANDER, GE ;
DELONG, MR ;
STRICK, PL .
ANNUAL REVIEW OF NEUROSCIENCE, 1986, 9 :357-381
[7]   CONTINUOUS LISURIDE EFFECTS ON CENTRAL DOPAMINERGIC MECHANISMS IN PARKINSONS-DISEASE [J].
BARONTI, F ;
MOURADIAN, MM ;
DAVIS, TL ;
GIUFFRA, M ;
BRUGHITTA, G ;
CONANT, KE ;
CHASE, TN .
ANNALS OF NEUROLOGY, 1992, 32 (06) :776-781
[8]  
BAROPNTI F, 1992, MOV DISORD S1, V7, P98
[9]   INVIVO INTERACTION OF CABERGOLINE WITH RAT-BRAIN DOPAMINE-RECEPTORS LABELED WITH [H-3] N-N-PROPYLNORAPOMORPHINE [J].
BENEDETTI, MS ;
DOSTERT, P ;
BARONE, D ;
EFTHYMIOPOULOS, C ;
PERETTI, G ;
RONCUCCI, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 187 (03) :399-408
[10]   PLEUROPULMONARY DISEASE ASSOCIATED WITH DOPAMINE AGONIST THERAPY [J].
BHATT, MH ;
KEENAN, SP ;
FLEETHAM, JA ;
CALNE, DB .
ANNALS OF NEUROLOGY, 1991, 30 (04) :613-616